BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Diagnosis
604 results:

  • 1. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
    Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
    Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
    Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
    Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
    Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
    Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer Risks Associated With
    Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
    JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators.
    Feng Y
    J Ovarian Res; 2024 Feb; 17(1):45. PubMed ID: 38378582
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
    Zheng G; Faber MT; Wang J; Baandrup L; Hertzum-Larsen R; Sundström K; Kjær SK
    Br J Cancer; 2024 May; 130(8):1279-1285. PubMed ID: 38347096
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
    Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
    Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
    Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Dabi Y; Rockall A; Razakamanantsoa L; Guerra A; Fournier LS; Fotopoulou C; Touboul C; Thomassin-Naggara I;
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():135-142. PubMed ID: 38237312
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
    Wang Y; Dackus GMHE; Rosenberg EH; Cornelissen S; de Boo LW; Broeks A; Brugman W; Chan TWS; van Diest PJ; Hauptmann M; Ter Hoeve ND; Isaeva OI; de Jong VMT; Jóźwiak K; Kluin RJC; Kok M; Koop E; Nederlof PM; Opdam M; Schouten PC; Siesling S; van Steenis C; Voogd AC; Vreuls W; Salgado RF; Linn SC; Schmidt MK
    BMC Med; 2024 Jan; 22(1):9. PubMed ID: 38191387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Significance of Ultra-Radical Surgery in Extensive Metastatic ovarian Growing Teratoma Syndrome.
    Li S; Wang T; Du H; Tang H; Zhang T; Zhang R; Zhang X; Yang J
    Oncology; 2023; 101(12):773-781. PubMed ID: 38096801
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of American College of Radiology ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
    Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
    J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. O-RADS scoring system for adnexal lesions: Diagnostic performance on TVUS performed by an expert sonographer and MRI.
    Campos A; Villermain-Lécolier C; Sadowski EA; Bazot M; Touboul C; Razakamanantsoa L; Thomassin-Naggara I
    Eur J Radiol; 2023 Dec; 169():111172. PubMed ID: 37976101
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
    Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
    Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anticipated time to seek medical advice for possible ovarian cancer symptoms and perceived barriers to early presentation among Palestinian women: a national cross-sectional study.
    Elshami M; Al-Madhoun S; Alser M; Al-Slaibi I; Yaseen A; Tuffaha A; Jabr H; Ubaiat S; Khader S; Khraishi R; Jaber I; Arafeh ZA; Alqattaa A; Hadi AAE; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Cancer; 2023 Oct; 23(1):975. PubMed ID: 37833659
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.